关注
LUCY HUTCHINSON
LUCY HUTCHINSON
在 roche.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
An introduction to machine learning
S Badillo, B Banfai, F Birzele, II Davydov, L Hutchinson, T Kam‐Thong, ...
Clinical pharmacology & therapeutics 107 (4), 871-885, 2020
3962020
Models and machines: how deep learning will take clinical pharmacology to the next level
L Hutchinson, B Steiert, A Soubret, J Wagg, A Phipps, R Peck, JE Charoin, ...
CPT: pharmacometrics & systems pharmacology 8 (3), 131, 2019
452019
Modeling longitudinal preclinical tumor size data to identify transient dynamics in tumor response to antiangiogenic drugs
LG Hutchinson, HJ Mueller, EA Gaffney, PK Maini, J Wagg, A Phipps, ...
CPT: Pharmacometrics & Systems Pharmacology 5 (11), 636-645, 2016
182016
Introduction of an artificial neural network–based method for concentration‐time predictions
DS Bräm, N Parrott, L Hutchinson, B Steiert
CPT: Pharmacometrics & Systems Pharmacology 11 (6), 745-754, 2022
142022
Integrating digital pathology and mathematical modelling to predict spatial biomarker dynamics in cancer immunotherapy
LG Hutchinson, O Grimm
NPJ Digital Medicine 5 (1), 92, 2022
92022
Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis
LG Hutchinson, EA Gaffney, PK Maini, J Wagg, A Phipps, HM Byrne
Journal of theoretical biology 398, 162-180, 2016
92016
Digital therapeutics as a new therapeutic modality: a review from the perspective of clinical pharmacology
B Ribba, R Peck, L Hutchinson, I Bousnina, D Motti
Clinical Pharmacology & Therapeutics 114 (3), 578-590, 2023
82023
An in silico Model of T Cell Infiltration Dynamics Based on an Advanced in vitro System to Enhance Preclinical Decision Making in Cancer Immunotherapy
TD Lewin, B Avignon, A Tovaglieri, L Cabon, N Gjorevski, LG Hutchinson
Frontiers in Pharmacology 13, 837261, 2022
82022
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg‐Depleting Antibody
S Belli, M Amann, L Hutchinson, L Pousse, A Abdolzade‐Bavil, N Justies, ...
Clinical Pharmacology & Therapeutics, 2024
2024
Optimization of biopsy scheduling in clinical studies of T cell bispecifics through an integrated modeling and simulation, digital pathology and machine learning approach
LG Hutchinson, A Soubret, B Ribba, JE Charoin, A Phipps, R Peck, ...
Cancer Research 79 (13_Supplement), 690-690, 2019
2019
Mathematical models of anti-angiogenic therapy and vessel normalisation
L Hutchinson
University of Oxford, 2017
2017
Population Approach Group Europe Population Approach Group Europe
L Hutchinson
系统目前无法执行此操作,请稍后再试。
文章 1–12